Radu Vasilcanu
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 5%
- Cancer Research
- Oncology
- Cellular and Molecular Neuroscience
- Co-authors
- Leonard GirnitaOlle LarssonBita SehatDaiana VasilcanuAda GirnitaRobert J. LefkowitzSudha K. ShenoyMagnus Axelson
- Topics
- Growth Hormone and Insulin-like Growth Factors (5 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)Ubiquitin and proteasome pathways (3 papers)
- Partner nations
- SwedenUnited States
In The Last Decade
Radu Vasilcanu
9 papers receiving 618 citations
Peers
Comparison fields: 5 of 55
- Molecular Biology 498
- Endocrinology, Diabetes and Metabolism 245
- Cancer Research 138
- Oncology 96
- Cellular and Molecular Neuroscience 80
Countries citing papers authored by Radu Vasilcanu
This map shows the geographic impact of Radu Vasilcanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radu Vasilcanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radu Vasilcanu more than expected).
Fields of papers citing papers by Radu Vasilcanu
This network shows the impact of papers produced by Radu Vasilcanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radu Vasilcanu. The network helps show where Radu Vasilcanu may publish in the future.
Co-authorship network of co-authors of Radu Vasilcanu
This figure shows the co-authorship network connecting the top 25 collaborators of Radu Vasilcanu. A scholar is included among the top collaborators of Radu Vasilcanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radu Vasilcanu. Radu Vasilcanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 64 | |
| 2 | 37 | |
| 3 | 116 | |
| 4 | 67 | |
| 5 | 20 | |
| 6 | 142 | |
| 7 | 40 | |
| 8 | 126 | |
| 9 | Vasilcanu D, Girnita A, Girnita L, Vasilcanu R, Axelson M, Larsson O.. The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway. Oncogene 23: 7854-7862 | 10 |
About Radu Vasilcanu
Radu Vasilcanu is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Molecular Biology, having authored 9 papers that have together received 622 indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (245 citations), Cancer Research (138 citations) and Molecular Biology (498 citations). Radu Vasilcanu has collaborated with scholars based in Sweden and United States. Frequent co-authors include Leonard Girnita, Olle Larsson, Bita Sehat, Daiana Vasilcanu, Ada Girnita, Robert J. Lefkowitz, Sudha K. Shenoy, Ada Girnita, Magnus Axelson and Sandra Andersson. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.